U.S. flag

An official website of the United States government

NM_017739.4(POMGNT1):c.880-1G>A AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 3, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003459586.1

Allele description [Variation Report for NM_017739.4(POMGNT1):c.880-1G>A]

NM_017739.4(POMGNT1):c.880-1G>A

Genes:
POMGNT1:protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-) [Gene - OMIM - HGNC]
TSPAN1:tetraspanin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p34.1
Genomic location:
Preferred name:
NM_017739.4(POMGNT1):c.880-1G>A
HGVS:
  • NC_000001.11:g.46193926C>T
  • NG_009205.3:g.31380G>A
  • NM_001243766.2:c.880-1G>A
  • NM_001290129.2:c.814-1G>A
  • NM_001290130.2:c.451-1G>A
  • NM_001410783.1:c.880-1G>A
  • NM_017739.4:c.880-1G>AMANE SELECT
  • LRG_701t1:c.880-1G>A
  • LRG_701t2:c.880-1G>A
  • LRG_701:g.31380G>A
  • NC_000001.10:g.46659598C>T
  • NM_001243766.1:c.880-1G>A
  • NM_017739.3:c.880-1G>A
Links:
dbSNP: rs1317832573
NCBI 1000 Genomes Browser:
rs1317832573
Molecular consequence:
  • NM_001243766.2:c.880-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001290129.2:c.814-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001290130.2:c.451-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001410783.1:c.880-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_017739.4:c.880-1G>A - splice acceptor variant - [Sequence Ontology: SO:0001574]

Condition(s)

Name:
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3
Synonyms:
WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMGNT1-RELATED; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3; Congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies, type A3
Identifiers:
MONDO: MONDO:0009667; MedGen: C3151519; OMIM: 253280

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004206002Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)		Pathogenic
(Mar 3, 2023) 		unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Baylor Genetics, SCV004206002.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 5, 2025